Phreesia Net Profit Margin 2019-2024 | PHR
Phreesia Net Profit Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Net Income | Net Margin |
2024-07-31 | $0.39B | $-0.10B | -25.90% |
2024-04-30 | $0.37B | $-0.12B | -32.09% |
2024-01-31 | $0.36B | $-0.14B | -38.66% |
2023-10-31 | $0.34B | $-0.15B | -42.77% |
2023-07-31 | $0.32B | $-0.15B | -47.81% |
2023-04-30 | $0.30B | $-0.16B | -53.97% |
2023-01-31 | $0.28B | $-0.18B | -62.63% |
2022-10-31 | $0.26B | $-0.18B | -70.23% |
2022-07-31 | $0.25B | $-0.18B | -73.47% |
2022-04-30 | $0.23B | $-0.16B | -68.86% |
2022-01-31 | $0.21B | $-0.12B | -54.93% |
2021-10-31 | $0.20B | $-0.08B | -40.10% |
2021-07-31 | $0.18B | $-0.05B | -27.93% |
2021-04-30 | $0.16B | $-0.03B | -19.63% |
2021-01-31 | $0.15B | $-0.03B | -18.24% |
2020-10-31 | $0.14B | $-0.02B | -16.55% |
2020-07-31 | $0.13B | $-0.02B | -13.43% |
2020-04-30 | $0.13B | $-0.08B | -63.85% |
2020-01-31 | $0.13B | $-0.09B | -73.60% |
2019-07-31 | $0.08B | $-0.10B | -117.86% |
2019-04-30 | $0.08B | $-0.04B | -51.28% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $1.148B | $0.356B |
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Tempus AI (TEM) | United States | $9.226B | 0.00 |
Inspire Medical Systems (INSP) | United States | $5.656B | 176.38 |
Hims & Hers Health (HIMS) | United States | $5.534B | 140.72 |
Enovis (ENOV) | United States | $2.608B | 17.68 |
Privia Health (PRVA) | United States | $2.587B | 215.60 |
IRhythm Technologies (IRTC) | United States | $2.316B | 0.00 |
Azenta (AZTA) | United States | $2.209B | 110.15 |
Omnicell (OMCL) | United States | $2.116B | 69.23 |
10x Genomics (TXG) | United States | $1.732B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.689B | 0.00 |
Schrodinger (SDGR) | United States | $1.518B | 0.00 |
Butterfly Network (BFLY) | United States | $0.690B | 0.00 |
Standard BioTools (LAB) | United States | $0.596B | 0.00 |
Talkspace (TALK) | United States | $0.583B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.547B | 0.00 |
Definitive Healthcare (DH) | United States | $0.505B | 87.40 |
Health Catalyst (HCAT) | United States | $0.495B | 0.00 |
Pulmonx (LUNG) | United States | $0.268B | 0.00 |
TruBridge (TBRG) | United States | $0.247B | 71.91 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
American Well (AMWL) | United States | $0.124B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.112B | 0.00 |
P3 Health Partners (PIII) | United States | $0.076B | 0.00 |
HeartBeam (BEAT) | United States | $0.074B | 0.00 |
111 (YI) | China | $0.052B | 0.00 |
CareCloud (CCLD) | United States | $0.046B | 0.00 |
Outset Medical (OM) | United States | $0.044B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
Zepp Health (ZEPP) | China | $0.037B | 0.00 |
Movano (MOVE) | United States | $0.023B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
MSP Recovery (LIFW) | United States | $0.013B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
Syra Health (SYRA) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.002B | 0.00 |
Zhongchao (ZCMD) | China | $0.002B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |